These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16823693)

  • 21. Human meningiomas: immunohistochemical localization of progesterone receptor and heat shock protein 27 and absence of estrogen receptor and PS2.
    Assimakopoulou M
    Cancer Detect Prev; 2000; 24(2):163-8. PubMed ID: 10917137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Behavior of estrogen and progesterone receptors in intracranial meningioma].
    Oddi G; Rebeck L; Bruni P
    Pathologica; 1989; 81(1075):515-22. PubMed ID: 2641153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New Insights into Expression of Hormonal Receptors by Meningiomas.
    Portet S; Banor T; Bousquet J; Simonneau A; Flores M; Ingrand P; Milin S; Karayan-Tapon L; Bataille B
    World Neurosurg; 2020 Aug; 140():e87-e96. PubMed ID: 32371078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
    Ozen O; Demirhan B; Altinörs N
    Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
    Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
    Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas.
    Takei H; Buckleair LW; Powell SZ
    Neuropathology; 2008 Feb; 28(1):62-8. PubMed ID: 18021195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of progesterone and estrogen receptor expression in 15 meningiomas of dogs and cats.
    Adamo PF; Cantile C; Steinberg H
    Am J Vet Res; 2003 Oct; 64(10):1310-8. PubMed ID: 14596471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
    Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
    Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma.
    Shayanfar N; Mashayekh M; Mohammadpour M
    Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy.
    Schrell UM; Adams EF; Fahlbusch R; Greb R; Jirikowski G; Prior R; Ramalho-Ortigao FJ
    J Neurosurg; 1990 Nov; 73(5):743-9. PubMed ID: 2213164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of soft tissue perineurioma and meningioma using a five-marker immunohistochemical panel.
    Agaimy A; Buslei R; Coras R; Rubin BP; Mentzel T
    Histopathology; 2014 Jul; 65(1):60-70. PubMed ID: 24393170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas.
    Amatya VJ; Takeshima Y; Sugiyama K; Kurisu K; Nishisaka T; Fukuhara T; Inai K
    Hum Pathol; 2001 Sep; 32(9):970-5. PubMed ID: 11567227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features.
    Markwalder TM; Zava DT; Goldhirsch A; Markwalder RV
    Surg Neurol; 1983 Jul; 20(1):42-7. PubMed ID: 6867927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The correlation between phosphorylated Histone H3 (PHH3) and p-STAT3 in Meningiomas.
    Ozek E; Akdag H; Tosuner Z; Abdallah A; Hatiboglu MA
    Clin Neurol Neurosurg; 2019 Mar; 178():46-50. PubMed ID: 30710729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen and progestin receptors in meningiomas: clinicopathological correlations.
    Markwalder TM; Markwalder RV; Zava DT
    Clin Neuropharmacol; 1984; 7(4):368-74. PubMed ID: 6509449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
    Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
    Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An audit of immunohistochemical marker patterns in meningioma.
    Baxter DS; Orrego A; Rosenfeld JV; Mathiesen T
    J Clin Neurosci; 2014 Mar; 21(3):421-6. PubMed ID: 24231566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progesterone and estrogen receptors: opposing prognostic indicators in meningiomas.
    Pravdenkova S; Al-Mefty O; Sawyer J; Husain M
    J Neurosurg; 2006 Aug; 105(2):163-73. PubMed ID: 17219818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is progesteron receptor status really a prognostic factor for intracranial meningiomas?
    Iplikcioglu AC; Hatiboglu MA; Ozek E; Ozcan D
    Clin Neurol Neurosurg; 2014 Sep; 124():119-22. PubMed ID: 25036873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and immunohistochemical expression levels of androgen, estrogen, progesterone and Ki-67 receptors in relationship with gross-total resected meningiomas relapse.
    Tao Y; Liang G; Li Z; Wang Y; Wu A; Wang H; Lu Y; Liu Z; Hu G
    Br J Neurosurg; 2012 Oct; 26(5):700-4. PubMed ID: 22616825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.